Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.
2.

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.

Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, Zgombick JM, Xu YC.

J Pharmacol Exp Ther. 2000 Aug;294(2):688-700.

PMID:
10900249
3.

Nicotine withdrawal leads to increased sensitivity of serotonergic neurons to the 5-HT1A agonist 8-OH-DPAT.

Rasmussen K, Czachura JF.

Psychopharmacology (Berl). 1997 Oct;133(4):343-6.

PMID:
9372532
4.
5.

The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle.

Rasmussen K, Czachura JF, Kallman MJ, Helton DR.

Neuroreport. 1996 Apr 10;7(5):1050-2.

PMID:
8804049
6.

Central nervous system characterization of the new cholecystokininB antagonist LY288513.

Helton DR, Berger JE, Czachura JF, Rasmussen K, Kallman MJ.

Pharmacol Biochem Behav. 1996 Mar;53(3):493-502.

PMID:
8866946
7.

Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons.

Rasmussen K, Czachura JF.

Neuroreport. 1995 Dec 29;7(1):329-32.

PMID:
8742482
8.

Quinazolinone cholecystokinin (CCK)-B antagonists decrease midbrain dopamine unit activity.

Rasmussen K, Yu MJ, Czachura JF.

Synapse. 1994 Aug;17(4):278-82. No abstract available.

PMID:
7992203
9.

Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.

Rasmussen K, Czachura JF, Stockton ME, Howbert JJ.

J Pharmacol Exp Ther. 1993 Jan;264(1):480-8.

PMID:
8423546
10.

Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.

Rasmussen K, Stockton ME, Czachura JF, Howbert JJ.

Eur J Pharmacol. 1991 Dec 10;209(1-2):135-8.

PMID:
1687681
11.

The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons.

Rasmussen K, Stockton ME, Czachura JF.

Eur J Pharmacol. 1991 Nov 19;205(1):113-6.

PMID:
1811993
12.

Chronic cocaine-induced supersensitivity id blocked by co-treatment with the peptide cyclo-(Leu-Gly).

Gonzalez LP, Czachura JF, Brewer KW.

NIDA Res Monogr. 1990;105:353-4. No abstract available.

PMID:
1876038
13.

Spontaneous versus elicited seizures following ethanol withdrawal: differential time course.

Gonzalez LP, Czachura JF, Brewer KW.

Alcohol. 1989 Nov-Dec;6(6):481-7.

PMID:
2597351
14.

Reduced behavioral responses to intranigral muscimol following chronic ethanol.

Gonzalez LP, Czachura JF.

Physiol Behav. 1989 Sep;46(3):473-7.

PMID:
2623072
15.

Ethanol withdrawal alters apomorphine-induced motility.

Gonzalez LP, Czachura JF.

Pharmacol Biochem Behav. 1988 Sep;31(1):163-8.

PMID:
3252246
16.

Apomorphine-induced hypothermia increases during ethanol withdrawal.

Gonzalez LP, Colbern DL, Czachura JF.

Alcohol. 1988 Mar-Apr;5(2):107-9.

PMID:
3395457

Supplemental Content

Loading ...
Support Center